Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures
Johnson, Margaret; Grinsztejn, Beatriz; Rodriguez, Claudia; Coco, Jeffrey; DeJesus, Edwin; Lazzarin, Adriano; Lichtenstein, Kenneth; Rightmire, Anna; Sankoh, Serap; Wilber, Richard
This paper has been removed from this issue because of typographical errors. The article was published in Volume 19(7), cover date 29 April 2005, pp. 685-694.
This article has been cited 20 time(s).
AIDS Research and Human RetrovirusesIncidence of Hyperbilirubinemia and Jaundice Due to Atazanavir in a Cohort of Hispanic PatientsAIDS Research and Human Retroviruses
AIDS Research and Human RetrovirusesShort Communication Fasting Increases Serum Concentrations of Bilirubin in Patients Receiving Atazanavir: Results from a Pilot StudyAIDS Research and Human Retroviruses
Janac-Journal of the Association of Nurses in AIDS CareCurrent clinical issues impacting the lives of patients living with HIV/AIDSJanac-Journal of the Association of Nurses in AIDS Care
International Journal of Std & AIDS
Practical discussion on switching studies and how this relates to managing lipids - Discussion
International Journal of Std & AIDS, 16():
Journal of HepatologyHepatotoxicity of antiretrovirals: Incidence, mechanisms and managementJournal of Hepatology
Journal of Infectious Diseases
The survival benefits of AIDS treatment in the United States
Journal of Infectious Diseases, 194(1):
Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes
Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial
Antiviral Therapy, 11(2):
Expert Opinion on Drug Metabolism & ToxicologyClinical pharmacology, efficacy and safety of atazanavir: a reviewExpert Opinion on Drug Metabolism & Toxicology
Evaluation of atazanavir C-trough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir
New Microbiologica, 28(2):
Expert Opinion on PharmacotherapyTreatment of dyslipidaemia in HIV-infected personsExpert Opinion on Pharmacotherapy
HIV MedicineBritish HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008HIV Medicine
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005)
HIV Medicine, 6():
Efficacy and safety of once-daily regimens in the treatment of HIV infection
Circulation-Cardiovascular GeneticsContribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals A Longitudinal StudyCirculation-Cardiovascular Genetics
Comparative pharmacogenomics of antiretroviral and cytotoxic treatments
Lancet Oncology, 7(1):
HIV Clinical TrialsPerformance of six different ritonavir-boosted protease inhibitor-based regimens in heavily anti retroviral-experienced HIV-infected patientsHIV Clinical Trials
AIDSAntiretroviral drugs and liver injuryAIDS
JAIDS Journal of Acquired Immune Deficiency SyndromesRescue Therapy With Once-Daily Atazanavir-Based Regimens for Antiretroviral-Experienced HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes
© 2005 Lippincott Williams & Wilkins, Inc.
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Data is temporarily unavailable. Please try again soon.